Snehal Khedkar

Snehal Khedkar is an experienced professional in the pharmaceutical industry, holding significant leadership roles in drug development and manufacturing. Most recently, Snehal served as Director of MSAT and Pharmaceutical Manufacturing at Ultragenyx from March 2022 to November 2022. Prior to that, Snehal worked as Associate Director of Technical Operations at Constellation Pharmaceuticals and held a similar title at Anokion, where responsibilities included leading the development of sterile injectable products for multiple sclerosis. Snehal's career also includes a role as Principal Scientist at Frequency Therapeutics, focusing on formulation development for innovative therapies, and as Senior Development Scientist at FORUM Pharmaceuticals, where formulation development for a Phase II compound was a key achievement. Academic credentials include a Ph.D. in Pharmaceutical Sciences from the Institute of Chemical Technology, Mumbai, and an MS in Pharmaceutical Sciences from the same institution.